Spot On Sciences LLC (Spot On Sciences) is a life-science company offering medical devices for collection, storage and transport of blood and bodily fluids that minimizes the risk of contamination. The company develops HemaspotTM-HF used for blood sample collection and shipping of blood samples at ambient temperatures; HemaspotTM-SE, a blood separation device that separates whole blood cells and serum; and HemaSpot HD, a larger sample collection membrane allows multiple punches to run variety of assays on a single sample. Its products find application in the fields of biobanking, clinical pharmacology, medical research, wellness tests, diagnostic testing, drug monitoring and veterinary testing. Spot On Sciences is headquartered in San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Spot On Sciences LLC
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Category segmentation
1.6. Geography segmentation
1.7. Market rivalry
1.8. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the key strengths of the leading players?
7.3. What are the most recent notable developments of the leading players?
8 Company Profiles
8.1. BASF SE
8.2. Braskem SA
8.3. Eastman Chemical Company
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related GlobalData research
About GlobalData
List of Tables
Table 1: South America bioplastics market value: $ million, 2017–22
Table 2: South America bioplastics market volume: thousand Tonnes, 2017–22
Table 3: South America bioplastics market category segmentation: % share, by value, 2017–2022
Table 4: South America bioplastics market category segmentation: $ million, 2017-2022
Table 5: South America bioplastics market geography segmentation: $ million, 2022
Table 6: South America bioplastics market value forecast: $ million, 2022–27
Table 7: South America bioplastics market volume forecast: thousand Tonnes, 2022–27
Table 8: BASF SE: key facts
Table 9: BASF SE: annual financial ratios
Table 10: BASF SE: key employees
Table 11: BASF SE: key employees Continued
Table 12: Braskem SA: key facts
Table 13: Braskem SA: annual financial ratios
Table 14: Braskem SA: key employees
Table 15: Eastman Chemical Company: key facts
Table 16: Eastman Chemical Company: annual financial ratios
Table 17: Eastman Chemical Company: key employees
Table 18: South America exchange rate, 2018–22
List of Figures
Figure 1: South America bioplastics market value: $ million, 2017–22
Figure 2: South America bioplastics market volume: thousand Tonnes, 2017–22
Figure 3: South America bioplastics market category segmentation: $ million, 2017-2022
Figure 4: South America bioplastics market geography segmentation: % share, by value, 2022
Figure 5: South America bioplastics market value forecast: $ million, 2022–27
Figure 6: South America bioplastics market volume forecast: thousand Tonnes, 2022–27
Figure 7: Forces driving competition in the bioplastics market in South America, 2022
Figure 8: Drivers of buyer power in the bioplastics market in South America, 2022
Figure 9: Drivers of supplier power in the bioplastics market in South America, 2022
Figure 10: Factors influencing the likelihood of new entrants in the bioplastics market in South America, 2022
Figure 11: Factors influencing the threat of substitutes in the bioplastics market in South America, 2022
Figure 12: Drivers of degree of rivalry in the bioplastics market in South America, 2022